Related Experiment Videos
Clinical efficacy of amiodarone
P E Nolan1, J Nappi, P T Pollak
1Department of Pharmacy Practice and Science, College of Pharmacy and Sarver Heart Center, University of Arizona, Tucson 85721-0207, USA.
Pharmacotherapy
|December 17, 1998
Summary
Amiodarone effectively manages atrial and ventricular arrhythmias, significantly reducing arrhythmic and sudden death by 29% in high-risk patients. This antiarrhythmic drug also lowers overall mortality by 13%.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Supraventricular and ventricular arrhythmias pose significant health risks.
- Effective management of these arrhythmias is crucial for patient outcomes.
- Amiodarone is an antiarrhythmic medication with a broad spectrum of action.
Purpose of the Study:
- To review the clinical efficacy of amiodarone.
- To determine the role of amiodarone in managing supraventricular and ventricular arrhythmias.
- To assess the effects of amiodarone on mortality.
Main Methods:
- Review of relevant clinical studies.
- Analysis of published reports on amiodarone's use.
- Meta-analysis of randomized trials.
Main Results:
- Amiodarone effectively prevents atrial fibrillation/flutter recurrences in up to 80% of patients.
- It is a potent suppressor of ventricular arrhythmias, reducing arrhythmic death post-myocardial infarction.
- Meta-analysis shows a 29% reduction in arrhythmic/sudden death and a 13% reduction in total mortality in high-risk patients.
Conclusions:
- Amiodarone demonstrates significant efficacy in managing a wide range of arrhythmias.
- It is a valuable antiarrhythmic agent for clinical practice.
- Amiodarone contributes to improved survival rates in high-risk cardiac patients.